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Context: Type 2 diabetes mellitus (T2DM) is a multi-factorial disease with several genetic 
and environmental factors known to be associated with the disease. Tumor necrosis factor-
alpha (TNF-α) acts on fat cells associated with increased insulin resistance and obesity 
and its increase can be associated with the prevalence of T2DM. Previous studies on the 
relationship between 308 G/A polymorphism in TNF-α and T2DM were not conclusive. 
The aim of this study was to investigate the association between 308 G/A polymorphism 
in TNF-α gene and T2DM using a systematic review and meta-analysis.
Evidence Acquisitions: In this systematic review we searched all published studies about the 
association between TNF 308 G/A polymorphism and T2DM through databases such as 
Scopus, Science direct, PubMed and Google scholar. A fixed or random effect model was 
used on the basis of heterogeneity. The heterogeneity was assessed using the I2 index. We 
used STATA software (version 11.2) for data analysis. 
Results: In 22 selected papers, the total number of T2DM and control subject was 8485 
and 8615, respectively. Odds ratios (ORs) with 95% confidence intervals(CI) for the GG 
genotype polymorphism 308 G/A in total, Asian populations and whites (Caucasian) were 
estimated as OR = 0.98 (95% CI: 0.96-1.00), OR = 0.96 (95% CI: 0.93 to 0.99) and OR =1.00 
(95% CI: 0.97 to 1.40). The Publication Bias/or heterogeneity was observed in this study. 
Conclusions: The present investigation have shown that 308 G/A polymorphism GG and 
GA genotypes in TNF-α gene cannot be considered as predictors of T2DM (P < 0.05).
ABSTRACT
Implication for health policy/practice/research/medical education:
In a systematic review on 22 selected papers, we found that 308 G/A polymorphism GG and GA genotypes in TNF-α gene 
cannot be considered as predictors of  type 2 diabetes mellitus (P < 0.05).
Please cite this paper as: Hasanpour Dehkordi A, Dousti  M, Kiani F, Zamanian Azodi M, Rezaei-Tavirani M, Sayehmiri K. 
Tumor necrosis factor-alpha 308 G/A polymorphism and type 2 diabetes mellitus; a systematic review and meta-analysis. J 
Nephropathol. 2018;7(1):25-31. DOI: 10.15171/jnp.2018.09.
1. Context
Diabetes mellitus (DM) is a chronic disease and is one 
of  the health challenges in the 21st century. Decrease in 
insulin secretion and/or resistance to it are known to be 
involved in the development of  DM (1). In general, DM 
refers to a heterogeneous group of  metabolic disorders 
characterized by decreased insulin action or resistance 
to it, or both and is divided into two main categories; 
diabetes type 1, and type 2. DM is generally characteristic 
by insulin resistance and decrease in insulin production 
(2). Approximately 90% of  the global epidemics of 
DM belongs to type 2 DM (T2DM) and it has become 
the fourth common cause of  death in most developed 
countries. According to the international diabetes 
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federation in 2003, the proportion of  diabetes, in the 
world, was 194 million people and it is estimated this 
number will increase to 366 million people in 2030 which 
will be mostly T2DM. Thus, due to increased demand for 
health care and the imposition of  economic pressures, 
diabetes (more specifically T2DM) has become an 
important challenge for different communities (3). 
There are known factors predisposing individuals 
to T2DM. It is a multi-factorial disease and several 
factors both genetics and environmental play role in its 
development. Because of  the magnitude, complexity and 
multi-factorial nature of  diabetes, the accurate diagnosis 
of  the genetic factors is difficult. Gene polymorphisms 
have been considered to be essential for the development 
of  disease. Genomic studies in several countries and 
different races have been performed to identify genes 
associated with T2DM (4-6). However, the exact gene 
(/or genes) involved in T2DM is not recognized. It 
seems that all genes involved in the pathway of  insulin 
biosynthesis in pancreatic insulin and obesity can be the 
potential candidates (7). So far, more than 200 genes have 
been identified. One of  these genes is tumor necrosis 
factor-alpha (TNF-α). As a regulator, TNF-α acts in fat 
cells and is associated with increased insulin resistance 
and obesity (8). Adipose tissue is an important source 
of  TNF-α. Thus TNF-α expression in human adipose 
tissue and muscle increases the risk of  obesity (9,10).
One of  the known polymorphisms in tumor necrosis 
factor-alpha (TNF-α) gene that is located on the short 
arm of  chromosome 6, is the displacement of  guanine 
with adenine at position 308 promotes the mentioned 
gene. In general, the results of  studies on the association 
between the TNF-α gene polymorphism and T2DM is 
inconsistent because in different populations different 
results have been found (11)
Today’s chronic diseases are major challenges for 
governments, nurses, healthcare professionals, families 
and the community (12-17). So, many social and 
economic costs are imposed annually on the family and 
society (18,19).
Despite many studies conducted in this field, in different 
countries and races, the existence or lack of  relationship 
between 308 G/A polymorphism of  TNF-α and the risk 
of  T2DM has not been clearly demonstrated. The aim 
of  this study was to investigate the association of  308 
G/A polymorphism in TNF-α gene and T2DM using a 
large-scale meta-analysis.
2. Evidence Acquisitions
2.1. Literature search and study selection
To find related documents, we searched the following 
(TNF-α) 308 G/A polymorphism and T2DM 
14 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Study flowchart 
 
  
 
 
 
 
 
 
 
 
123 studies identified through database 
searching 
89 records excluded because of duplication 
34 records screened  
6 records 
excluded 
Full text of 28 articles assessed 
for eligibility 
24 studies included in qualitative 
synthesis 
22 of studies included in quantitative 
synthesis 
(meta‐analysis) 
4 excluded because of 
lack of required 
information  
literature databases: Scopus, PubMed, and Google 
scholar, SID, Irandoc and Magiran. We performed 
article search mainly using systematic search for all 
possible combinations of  English key words, the major 
and sensitive ones and their equivalent keywords. We 
searched based on keywords; TNF-α, type 2 DM and 
polymorphism. To determine the scope of  this study, 
case-control studies and meta-analysis of  previous 
articles were collected. The article selection was as 
follows; 1) a related case-control study and 2) having 
complete data about genotype and adequate alleles. All 
searches were performed independently by two people. 
Under this process, in initial inquiry we found 37 articles 
conducted during 1995 to 2013. The main criterion to 
select papers in this study, was referring to the association 
between gene, polymorphisms of  TNF-α with T2DM. 
We added all relevant papers to the initial list. Studies 
about clinical decision making or those about clinical 
characteristics of  patients or those not related to the 
topic of  the research are excluded.  The 8 non-relevant 
articles were removed and 29 articles’ abstracts were 
investigated. Due to the unavailability of  full texts, the 
2 papers’ abstracts were deleted and the full texts of  27 
articles were investigated for the quality and finally, 22 
articles were analyzed (Figure 1). 
2.2. Statistical analysis
We extracted from each article the following data; the 
number of  controls, number of  cases, the presence of 
genotypes GG, GA and AA polymorphism 308 G/A 
in cases and controls, age, sex and year of  publication 
Figure 1. Study flowchart.
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of  the paper. Odds ratios (ORs) and its 95% confidence 
intervals (CIs) were calculated for each study. 
Peto method was used to calculate OR and pooled 
OR. The heterogeneity was assessed using the Q and I2 
indexes. Begg’s funnel plot was used to check publication 
bias. The data were analyzed using R program (version 
2/15/1) and Stata (version 11.2). Additionally P value 
less than 0.05 was considered as statistical significance.
3. Results
In 22 reviewed papers, the total number of  T2DM and 
control subjects were 8485 and 8615, including 6003 
cases and 5683 controls with genotype GG, 2136 cases 
and 2433 controls with GA. AA genotypes were found 
among 198 cases and 408 controls. The European, 
Australian, Mexican, Japanese, Indian, Chinese, Brazilian, 
Chilean, and Iranian populations have been studied 
from 1995 to 2013. Characteristics of  the studies are 
summarized in Table 1.
According to the results from the Random Effects 
Model, OR (0.99) and 95% CIs (from 0.97 to 1.01) 
were estimated. There was no significant association 
between GG genotype and T2DM (P > 0.05). Due to the 
heterogeneity of  the studies (I2 Index=1.82), the CIs for 
each study based on a Random Effects Model is given 
in Figure 1.
The results of  three studies carried out by Zeggini et 
al,27 Guzmán-Flores et al,22 and Golshani et al, to GG 
genotype illustrate its protective role against T2DM 
(Figure 1), while in study conducted by Boraska et al,26 it 
has been indicated that individuals having GG genotype 
are 1.46-folds higher at risk of  T2DM. In the 17 
studies, there was no significant difference between GG 
genotype and the susceptibility to T2DM. Combining the 
results of  all 21 studies, it has been shown no significant 
relationship between GG genotype polymorphism 
308 G/A genes in TNF-α and susceptibility to T2DM 
(Figure 1).
In Figure 2, we found the publication bias has no 
influence on GG genotype indicated by the symmetry 
of  the funnel. The size of  the circles has shown the 
precision of  the studies. Thus, the greater the circles, the 
greater the samples sizes, and vice versa (Figure 3).
4. Discussion 
The results of  the present study have shown that 308 
G/A polymorphism GG and GA genotypes in TNF-α 
gene cannot be considered as predictors of  T2DM 
Table 1. The characteristics of  different articles related to 308G/A (TNF-α) and susceptibility to type 2 diabetes mellitus
Authors’ name Publication year Country Case (n)
Control 
(n)
Case/Control
(age year)
GG GA+ AA
References
Case Total Case Total
Heijmans et al 2002 Netherlands 79 577 >85 51 429 28 227 (20)
Perez-Luque et al 2012 Mexico 95 135 49.5/52 72 188 23 42 (21)
Guzmán-Flores et al 2011 Mexico 518 1290 — 438 1581 80 227 (22)
Li et al 2003 Finland 395 284 65.7/55.0 273 462 122 217 (23)
Furuta et al 2002 Japan 132 142 55.6/51.8 129 268 3 6 (24)
Bouhaha et al 2010 Tunis 228 300 43.8/60.6 204 345 95 149 (25)
Boraska et al 2010 UK 1454 2504 — 938 2571 516 1387 (26)
Zeggini et al 2005 UK 834 1231 — 484 1263 292 726 (27)
Kim et al 2006 Korea 169 198 — 174 315 24 52 (28)
Lindholm et al 2008 Sweden 2957 206 61.2/59.7 1908 2041 1019 1091 (29)
Ishii et al 2000 Japan 71 299 58.76/41.96 69 359 2 11 (30)
Morris et al 2003 Australia 91 189 — 52 178 38 101 (31)
Liu et al 2008 China 245 122 48.2/46.5 222 331 23 36 (32)
Hamann et al 1995 German 138 57 57.9/56.1 108 154 30 41 (33)
Padovani et al 2000 Brazil 21 145 43/42 17 128 4 38 (34)
Ko et al 2003 China 339 202 38.2/36.8 284 455 55 86 (35)
Santos et al 2006 Chile 30 53 69–60 27 72 3 11 (26)
Shiau et al 2003 China 261 189 58.73/58.16 218 386 39 58 (37)
Tsiavou et al 2004 Greece 32 39 51/44 29 61 3 10 (38)
Vendrell et al 2003 Spain 135 207 56.67 109 268 26 74 (39)
Dutta et al 2013 India 122 100 — 76 147 46 75 (40)
Golshani et al 2013 Iran 173 173 50.4/54.1 146 308 27 38 Unpublished
Total 8485 8615 6003 12310 2498 4703
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(P < 0.05).
 The results of  a similar study conducted by Feng et al in 
2010 (41) have shown no significant relationship between 
gene 308 G/A polymorphism TNF-α and T2DM.
In this study we added the result of  four conducted 
studies from 2010 to 2013 to the result of  study 
performed by Feng et al. In his another work, Feng 
shows that the high levels of  polymorphism 308 G/A 
allele of  TNF-α gene is a risk factor for diabetes type 1 
(42). In a research by Furuta et al carried in Japan on 308 
G/A, 132 diabetic patients and 142 healthy controls, the 
association between single nucleotide polymorphisms in 
the TNF-α gene promoter region was found in diabetic 
patients and controls (24).
Mukhopadhyaya et al, in a work performed by the Indian 
population of  40 diabetic patients and 40 control subjects 
have found an association between single nucleotide 
polymorphisms in the promoter region of  genes 308- 
G/A TNF-α and T2DM (43).
Costa et al evaluated 36 patients with diabetes and 41 
control subjects. Low 863 G/A TNF-α allele and a high 
concentration of  soluble receptor-2 (TNFR2) TNF-α 
were associated with the higher incidence of  diabetes 
type 2. This article has shown that there is an abnormal 
increase of  TNF-α disease, which is closely related to 
genetics, metabolism and indicated T2DM indexes (44).
This meta-analysis study aimed to investigate the 
association between polymorphisms in G/A 308 
gene TNF-α and metabolic syndrome. The findings 
demonstrate that allele A–TNF increases the risk of 
metabolic syndrome (45). Additionally, in another study, 
a significant association between increased body mass 
Figure 2. Meta-analysis of  the GG genotype308G/A with T2DM. Square 
represent effect estimate of  individual studies with their 95% confidence 
intervals with size of  squares proportional to the weight assigned to the 
study in the meta-analysis
Figure 3. Begg’s Funnel plot for evaluation of  publication bias.
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Figure 3. Begg‘s Funnel plot for evaluation of publication bias. 
 
 
 
 
index and polymorphisms has been reported in Swedish 
women (29).
In a meta-analysis conducted on Han Chinese population, 
10 studies including 1425 diabetic patients and 1116 
healthy controls were studied. The results have shown 
that A<G-308 polymorphism is a major risk factor 
for T2DM and at the locus of  A allele may be critical 
for the development of  T2DM in the Han Chinese 
population (46). Results have shown that in other races, 
including the Whites (27,28,33) and Japanese (24,30) 
polymorphism A<G 308 TNF-α is not a risk factor for 
the development of  T2DM. Hence, it is concluded that 
the race of  the subjects is an important factor in making 
final conclusion.
According to previous studies conducted in different 
populations, the overall conclusion of  this study was 
that there was no significant association between allelic 
sequences in 308 G/A gene for tumor necrosis factor-
alpha (TNF-α) and the risk of  T2DM. However, T2DM 
and insulin resistance is multi-factorial disorders in which 
diverse genetic locus susceptibility involved in disease 
occurrence. Environmental factors (such as nutrition 
and physical activity) are also, effective in development 
of  this phenotypic occurrence (47). Besides, other 
factors such as obesity, lack of  physical activity and diet 
are involved in the development of  such disease (48). In 
general, the result of  TNF-α gene polymorphism and 
T2DM is inconsistent. Depending on the population 
studied, it shows various effects (11). Here, we should 
remind that populations with a high incidence of 
T2DM are widespread, for example in the Pima Indian 
population that cannot be dedicated to environmental 
factors (49).
5. Conclusions
In general, it is suggested that we need to have in future 
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research, not only to recruit more samples but also focus 
on environmental factors such as ethnic differences.
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